Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
#STSS making a move
$CRXT Loading those cheapies right now ! once news drop, the skies is the limit here
$2.00 plus
$STSS
DD for any new eyes:
-Recent IPO at 4.25
-Low-float of 5.4m
-Insider buys ranging from 1.20 to 4.25
-Patented and FDA approved product
-Low dead space syringes = more doses per vial of medication
-Needlestick prevention
-Can only be used once
-FDA approved and CE marked manufacturing facility
-Net tangible value post-IPO dilution is at least 2x current SP
-Former CEO and current chairman served as president (head of vaccines) for Merck for nearly 30 years
-Recently acquired Safeguard Medical
-Several potential catalysts expected in the coming months
#STSS Razor Thin $$$$$$$$$$$$
#STSS @ $1.10 setting up for massive gains $$$$
$STSS Looks like another BREAKOUT move coming here folks !!
$2.00 plus possible
$ABVC long @ 0.91
great r/r, no shares available to short, insider bought 7 Million shares few days ago, great chart and former supernova, bottomed chart. Zacks has Price Target $9.50 six days ago!
Could run anytime
https://abvcpharma.com/
$ABVC long @1.05
great r/r, no shares available to short, insider bought 7 Million shares few days ago, great chart and former supernova, bottomed chart. Zacks has PT $9.50 six days ago!
Could run anytime and big, ww!
$STSS this can be the next AHPI from a few years ago when it went from $1.00 area to the $45.00 area in just 4 months, over ventilator stock euphoria. I can see syringes getting similar attention as we head into the fall season and benefiting STSS.
$STSS @ $1.20 - Oversold & ready for massive run - very low float - news coming up anyday !! i have loaded a few more today Short term target $2.00 plus mid $3.50 & Long $10.00 plus imo.
#STSS @ $1.20 - Oversold & ready for massive run - very low float
#STSS @ $1.20 - Oversold & ready for massive run - very low float
#CRXT ! Loading cheapies here, waiting for 1.00 dollar break then 1 year target
of $9.00 bucks $$$$$$$$$$$$$ #oversold #buythefear #reapbankslater
The stock market is a device to transfer money from the inpatient to the PAYtient ….. W Buffet
I believe news will drop sooner than later
#MXSG
Joint venture
#MXSG
#CRXT @0.53 Up 23% ! Squeeeezing the shorts !! $1.00 dollar break near folks
$9.00 Target
Boooming
#CRXT @0.53 Up 23% ! Squeeeezing the shorts !! $1.00 dollar break near folks
$9.00 Target
#MXSG @0.0037 Added for a 5x10 Fold run imo.
Gold Bargain stock !! It runs thin & low float
#MXSG @0.0037 Added for a 5x10 Fold run imo.
Gold Bargain stock !! It runs thin & low float
#MXSG @0.0037 Added for a 5x10 Fold run imo.
Gold Bargain stock !!
SHORT SQUEEZE $$$ #CRXT $1.00 plus next week $$$
Long term target $9.00
SHORT SQUEEZE $$$ #CRXT $1.00 plus next week $$$
Long term target $9.00
#CRXT @0.38 Bargain Alert !! Rated a buy with $9.00 price target $$$$
Needham Thinks Clarus Therapeutics Holdings’ Stock is Going to Recover
May 17 2022 - 06:16AM
TipRanks
Alert
Needham analyst Serge Belanger maintained a Buy rating on Clarus Therapeutics Holdings (CRXT – Research Report) today and set a price target of $3.00. The company's shares closed last Monday at $0.54, close to its 52-week low of $0.42. According to TipRanks.com, Belanger is a 2-star analyst with an average return of -0.3% and a 40.8% success rate. Belanger covers the Healthcare sector, focusing on stocks such as Amphastar Pharmaceuticals, Collegium Pharmaceutical, and KalVista Pharmaceuticals. Clarus Therapeutics Holdings has an analyst consensus of Moderate Buy, with a price target consensus of $3.00. See the top stocks recommended by analysts >> The company has a one-year high of $9.
https://www.tipranks.com/news/blurbs/needham-thinks-clarus-therapeutics-holdings-stock-is-going-to-recover-2?utm_source=advfn.com&utm_medium=referral
#CRXT @0.38 Bargain Alert !! Rated a buy with $9.00 price target $$$$
Needham Thinks Clarus Therapeutics Holdings’ Stock is Going to Recover
May 17 2022 - 06:16AM
TipRanks
Alert
Needham analyst Serge Belanger maintained a Buy rating on Clarus Therapeutics Holdings (CRXT – Research Report) today and set a price target of $3.00. The company's shares closed last Monday at $0.54, close to its 52-week low of $0.42. According to TipRanks.com, Belanger is a 2-star analyst with an average return of -0.3% and a 40.8% success rate. Belanger covers the Healthcare sector, focusing on stocks such as Amphastar Pharmaceuticals, Collegium Pharmaceutical, and KalVista Pharmaceuticals. Clarus Therapeutics Holdings has an analyst consensus of Moderate Buy, with a price target consensus of $3.00. See the top stocks recommended by analysts >> The company has a one-year high of $9.
https://www.tipranks.com/news/blurbs/needham-thinks-clarus-therapeutics-holdings-stock-is-going-to-recover-2?utm_source=advfn.com&utm_medium=referral
OVERSOLD !! Watch for a run back to $1.00 plus soon imo.
#CRXT
#CRXT @0.46 Rated a buy with $9.00 price target $$$$
Needham Thinks Clarus Therapeutics Holdings’ Stock is Going to Recover
May 17 2022 - 06:16AM
TipRanks
Alert
Needham analyst Serge Belanger maintained a Buy rating on Clarus Therapeutics Holdings (CRXT – Research Report) today and set a price target of $3.00. The company's shares closed last Monday at $0.54, close to its 52-week low of $0.42. According to TipRanks.com, Belanger is a 2-star analyst with an average return of -0.3% and a 40.8% success rate. Belanger covers the Healthcare sector, focusing on stocks such as Amphastar Pharmaceuticals, Collegium Pharmaceutical, and KalVista Pharmaceuticals. Clarus Therapeutics Holdings has an analyst consensus of Moderate Buy, with a price target consensus of $3.00. See the top stocks recommended by analysts >> The company has a one-year high of $9.
https://www.tipranks.com/news/blurbs/needham-thinks-clarus-therapeutics-holdings-stock-is-going-to-recover-2?utm_source=advfn.com&utm_medium=referral
#CRXT @0.46 Rated a buy with $9.00 price target $$$$
Needham Thinks Clarus Therapeutics Holdings’ Stock is Going to Recover
May 17 2022 - 06:16AM
TipRanks
Alert
Needham analyst Serge Belanger maintained a Buy rating on Clarus Therapeutics Holdings (CRXT – Research Report) today and set a price target of $3.00. The company's shares closed last Monday at $0.54, close to its 52-week low of $0.42. According to TipRanks.com, Belanger is a 2-star analyst with an average return of -0.3% and a 40.8% success rate. Belanger covers the Healthcare sector, focusing on stocks such as Amphastar Pharmaceuticals, Collegium Pharmaceutical, and KalVista Pharmaceuticals. Clarus Therapeutics Holdings has an analyst consensus of Moderate Buy, with a price target consensus of $3.00. See the top stocks recommended by analysts >> The company has a one-year high of $9.
https://www.tipranks.com/news/blurbs/needham-thinks-clarus-therapeutics-holdings-stock-is-going-to-recover-2?utm_source=advfn.com&utm_medium=referral
#CRXT @0.46 Rated a buy with $9.00 price target $$$$
Needham Thinks Clarus Therapeutics Holdings’ Stock is Going to Recover
May 17 2022 - 06:16AM
TipRanks
Alert
Needham analyst Serge Belanger maintained a Buy rating on Clarus Therapeutics Holdings (CRXT – Research Report) today and set a price target of $3.00. The company's shares closed last Monday at $0.54, close to its 52-week low of $0.42. According to TipRanks.com, Belanger is a 2-star analyst with an average return of -0.3% and a 40.8% success rate. Belanger covers the Healthcare sector, focusing on stocks such as Amphastar Pharmaceuticals, Collegium Pharmaceutical, and KalVista Pharmaceuticals. Clarus Therapeutics Holdings has an analyst consensus of Moderate Buy, with a price target consensus of $3.00. See the top stocks recommended by analysts >> The company has a one-year high of $9.
https://www.tipranks.com/news/blurbs/needham-thinks-clarus-therapeutics-holdings-stock-is-going-to-recover-2?utm_source=advfn.com&utm_medium=referral
Looking for $1.00 plus after quarter reports today
#CRXT
Boooooming indeed !!!
#CRXT $$$$$$$$$$$$$$$$$$$$
Off to the races we go !!!
#CRXT
Break 0.70 & we got a massive gainer
#CRXT
$1.00 plus this week imo.
$10.00 plus by summer time $$$
#CRXT $$$$$
$1,00 plus this week imo. #OVERSOLD
#TargetPPS$10.00 Bucks $$$
#CRXT
Big bounce next week imo.
problably $1.00 plus
#CRXT
#STSS sure looks like $2.00 plus sooner then later - Target $10.00 by end of may imo.
Dont you see 1.05 plus breaking ? R u trying to short the stock? better cover dude
Amem to that !
Same here ez, I have not trade a otc play since September of last year. New rules kind screwed up that market
Lol
No bro
Good to see you
Looking for a 0.0001 anyway